re: Ann: Phylogica - New Potential For Treati...
I think it does sound very interesting but will have to wait & see what happens from here. Nice to have in the basket though. The other partnerships are still the drivers at this point chasing the high value targets the big pharmas have chosen.
TBI is a huge market mainly because it is one that remains largely unmet & as of this point not many large pharmaceutical companies are working there - lets call it the "too hard basket" most funding is via charities/government/Army. Although word on the street is interest is starting to pick up from a few articles published recently. Obviously with patent expirys closing in it would make sense for the pharmaceutical companies agressivley seeking new areas to focus their attention - time will tell.
PYC Price at posting:
7.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)